Nurix Therapeutics Announces Webcast to Review Data from its Phase 1 Clinical Trial of BTK Degrader, NX-2127, Presented at the 64th American Society of Hematology Annual Meeting

Author's Avatar
Dec 07, 2022

Webcast Scheduled for Monday, December 12, 2022 at 8:30 PM CT (9:30 PM ET)